Document Detail


Drug-Related Death Following Release from Prison: A Brief Review of the Literature with Recommendations for Practice.
MedLine Citation:
PMID:  21834754     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Mortality from drug-related death is a significant contributor to the loss of life of young people in the UK. Despite attention, the high death rate from this cause continues to persist. One of the most frequently cited factors involved in drug-related death (DRD) is release from prison. This review aims to examine the published literature with a view to quantifying the risk associated with recent prison release and identifying risk factors and prevention strategies. Most deaths following release from prison are caused by overdose, usually from opioid use. The risk of death is greatest within the first week of release but, when compared with the general population, continues to be elevated for several weeks. Relative risk estimates suggest that those released from prison are up to 40 times more likely to die than similar individuals from the general population. Other than gender and an association with poor mental health, there is little in the way of robust risk factors for post-release death that could be identified from the literature. In-prison pharmacological maintenance treatment with methadone and buprenorphine has been shown to reduce the rate of heroin use, in the period immediately following release, in a small number of randomised controlled trials. It is widely recognised that continuity of care, of any form, is critical in avoiding DRDs. For problem drug users, packages of education, including information on the associated risks, treatments, and recognition of DRD after release from prison, are seen as a basic minimum requirement of the prison services. However, special protocols may be required for those drugusing prisoners who have a possibility of being released at short notice.
Authors:
D Leach; P Oliver
Related Documents :
24981754 - Performance-driven, pulmonary delivery of systemically acting drugs.
23629744 - Species differences in the dissolution and absorption of griseofulvin and albendazole, ...
25066074 - Electrospinning of diosmin from aqueous solutions for improved dissolution and oral abs...
22233294 - Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manuf...
3427544 - Persistence of the electrophysiologic effects of mexiletine in canine purkinje fibers a...
7596954 - Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-12
Journal Detail:
Title:  Current drug abuse reviews     Volume:  -     ISSN:  1874-4745     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101468123     Medline TA:  Curr Drug Abuse Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
University of Sheffield, Academic Unit of Primary Medical Care, Samuel Fox House, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK. p.oliver@sheffield.ac.uk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dopamine Neurons in the Ventral Tegmental Area: Drug-induced Synaptic Plasticity and Its Role in Rel...
Next Document:  L-Asparaginase and Inhibitors of Glutamine Synthetase Disclose Glutamine Addiction of ?-Catenin-Muta...